

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.85606037 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.85606037 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.63168927 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.63168927 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.55387981 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.10072663 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.05156215 |
| 8 | kynurenine metabolic process (GO:0070189) | 4.69755103 |
| 9 | urea metabolic process (GO:0019627) | 4.67848872 |
| 10 | urea cycle (GO:0000050) | 4.67848872 |
| 11 | cysteine metabolic process (GO:0006534) | 4.54722117 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 4.51940716 |
| 13 | tryptophan catabolic process (GO:0006569) | 4.51940716 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.51940716 |
| 15 | lysine metabolic process (GO:0006553) | 4.50712061 |
| 16 | lysine catabolic process (GO:0006554) | 4.50712061 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 4.50091162 |
| 18 | bile acid biosynthetic process (GO:0006699) | 4.43145933 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.41458328 |
| 20 | glyoxylate metabolic process (GO:0046487) | 4.38967870 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.35701937 |
| 22 | regulation of triglyceride catabolic process (GO:0010896) | 4.35391816 |
| 23 | negative regulation of cholesterol transport (GO:0032375) | 4.32020700 |
| 24 | negative regulation of sterol transport (GO:0032372) | 4.32020700 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 4.26177665 |
| 26 | tryptophan metabolic process (GO:0006568) | 4.23417902 |
| 27 | phospholipid efflux (GO:0033700) | 4.20578254 |
| 28 | complement activation, alternative pathway (GO:0006957) | 4.19942080 |
| 29 | Golgi transport vesicle coating (GO:0048200) | 4.17631528 |
| 30 | COPI coating of Golgi vesicle (GO:0048205) | 4.17631528 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.11035474 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.10197655 |
| 33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.07603535 |
| 34 | protein carboxylation (GO:0018214) | 4.07603535 |
| 35 | regulation of cholesterol esterification (GO:0010872) | 4.04220537 |
| 36 | NADH metabolic process (GO:0006734) | 4.00165995 |
| 37 | regulation of cholesterol homeostasis (GO:2000188) | 3.99816499 |
| 38 | bile acid metabolic process (GO:0008206) | 3.99276794 |
| 39 | homocysteine metabolic process (GO:0050667) | 3.99269917 |
| 40 | regulation of protein activation cascade (GO:2000257) | 3.98764330 |
| 41 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.96129604 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 3.92233836 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 3.90140913 |
| 44 | barbed-end actin filament capping (GO:0051016) | 3.84191606 |
| 45 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.83916189 |
| 46 | regulation of fibrinolysis (GO:0051917) | 3.81531165 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 3.80931150 |
| 48 | macromolecular complex remodeling (GO:0034367) | 3.80931150 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 3.80931150 |
| 50 | glutamate metabolic process (GO:0006536) | 3.80603718 |
| 51 | drug catabolic process (GO:0042737) | 3.79636461 |
| 52 | regulation of complement activation (GO:0030449) | 3.75956368 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 3.75048884 |
| 54 | cholesterol efflux (GO:0033344) | 3.73941320 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 3.72307581 |
| 56 | mannose metabolic process (GO:0006013) | 3.71172577 |
| 57 | triglyceride homeostasis (GO:0070328) | 3.69463181 |
| 58 | acylglycerol homeostasis (GO:0055090) | 3.69463181 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 3.69263091 |
| 60 | plasma lipoprotein particle assembly (GO:0034377) | 3.64105354 |
| 61 | intestinal cholesterol absorption (GO:0030299) | 3.63700784 |
| 62 | phospholipid homeostasis (GO:0055091) | 3.63199674 |
| 63 | alpha-amino acid catabolic process (GO:1901606) | 3.62736742 |
| 64 | positive regulation of lipid catabolic process (GO:0050996) | 3.61400788 |
| 65 | aromatic amino acid family metabolic process (GO:0009072) | 3.59584915 |
| 66 | bile acid and bile salt transport (GO:0015721) | 3.55679389 |
| 67 | 2-oxoglutarate metabolic process (GO:0006103) | 3.50070328 |
| 68 | angiotensin maturation (GO:0002003) | 3.48830746 |
| 69 | protein localization to endosome (GO:0036010) | 3.48036939 |
| 70 | short-chain fatty acid metabolic process (GO:0046459) | 3.46915409 |
| 71 | protein-lipid complex assembly (GO:0065005) | 3.45759668 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 3.44846834 |
| 73 | tyrosine metabolic process (GO:0006570) | 3.42629162 |
| 74 | coenzyme catabolic process (GO:0009109) | 3.42537231 |
| 75 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.41866164 |
| 76 | aspartate family amino acid catabolic process (GO:0009068) | 3.36277889 |
| 77 | acetyl-CoA metabolic process (GO:0006084) | 3.33841836 |
| 78 | ethanol oxidation (GO:0006069) | 3.33322570 |
| 79 | regulation of early endosome to late endosome transport (GO:2000641) | 3.31709120 |
| 80 | ketone body metabolic process (GO:1902224) | 3.31308765 |
| 81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.31004932 |
| 82 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.31004932 |
| 83 | flavonoid metabolic process (GO:0009812) | 3.29390559 |
| 84 | regulation of bile acid biosynthetic process (GO:0070857) | 3.27629254 |
| 85 | cholesterol homeostasis (GO:0042632) | 3.25181543 |
| 86 | glucose 6-phosphate metabolic process (GO:0051156) | 3.25180090 |
| 87 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.25132458 |
| 88 | sterol homeostasis (GO:0055092) | 3.21073535 |
| 89 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.19462497 |
| 90 | glycosphingolipid catabolic process (GO:0046479) | 3.18771050 |
| 91 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.18292315 |
| 92 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.17783121 |
| 93 | fatty acid beta-oxidation (GO:0006635) | 3.17157141 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 3.16586992 |
| 95 | exogenous drug catabolic process (GO:0042738) | 3.15357995 |
| 96 | regulation of extracellular matrix disassembly (GO:0010715) | 3.13952633 |
| 97 | fatty acid oxidation (GO:0019395) | 3.12625159 |
| 98 | indolalkylamine metabolic process (GO:0006586) | 3.12126590 |
| 99 | cellular glucuronidation (GO:0052695) | 3.10274107 |
| 100 | carboxylic acid catabolic process (GO:0046395) | 3.08093138 |
| 101 | organic acid catabolic process (GO:0016054) | 3.08093138 |
| 102 | lipid oxidation (GO:0034440) | 3.06720361 |
| 103 | monocarboxylic acid catabolic process (GO:0072329) | 3.06313142 |
| 104 | lipoprotein metabolic process (GO:0042157) | 3.05860094 |
| 105 | fatty acid transmembrane transport (GO:1902001) | 3.05169929 |
| 106 | protein retention in ER lumen (GO:0006621) | 3.04998020 |
| 107 | plasma lipoprotein particle organization (GO:0071827) | 3.04712472 |
| 108 | fatty acid catabolic process (GO:0009062) | 3.04657201 |
| 109 | glycolipid catabolic process (GO:0019377) | 3.03011591 |
| 110 | serine family amino acid metabolic process (GO:0009069) | 3.02144323 |
| 111 | stress fiber assembly (GO:0043149) | 3.01111401 |
| 112 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.00975042 |
| 113 | negative regulation of lipase activity (GO:0060192) | 2.99002408 |
| 114 | intestinal absorption (GO:0050892) | 2.98749803 |
| 115 | regulation of cholesterol metabolic process (GO:0090181) | 2.97999839 |
| 116 | protein-lipid complex subunit organization (GO:0071825) | 2.97891936 |
| 117 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.97771983 |
| 118 | arginine metabolic process (GO:0006525) | 2.97210856 |
| 119 | pinocytosis (GO:0006907) | 2.96659868 |
| 120 | response to laminar fluid shear stress (GO:0034616) | 2.93567681 |
| 121 | adhesion of symbiont to host (GO:0044406) | 2.92282878 |
| 122 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.91605100 |
| 123 | low-density lipoprotein particle clearance (GO:0034383) | 2.87756921 |
| 124 | proline biosynthetic process (GO:0006561) | 2.84988077 |
| 125 | fructose metabolic process (GO:0006000) | 2.83760834 |
| 126 | embryonic process involved in female pregnancy (GO:0060136) | 2.80685516 |
| 127 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.80683190 |
| 128 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.80064522 |
| 129 | virion attachment to host cell (GO:0019062) | 2.79669247 |
| 130 | adhesion of symbiont to host cell (GO:0044650) | 2.79669247 |
| 131 | peptide catabolic process (GO:0043171) | 2.76992401 |
| 132 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.76679448 |
| 133 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.68184361 |
| 134 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.64895995 |
| 135 | positive regulation of pseudopodium assembly (GO:0031274) | 2.62973441 |
| 136 | pentose-phosphate shunt (GO:0006098) | 2.62647491 |
| 137 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.58096249 |
| 138 | basement membrane organization (GO:0071711) | 2.56473050 |
| 139 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.56163850 |
| 140 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.53938903 |
| 141 | adherens junction assembly (GO:0034333) | 2.52155634 |
| 142 | positive regulation of receptor recycling (GO:0001921) | 2.51368191 |
| 143 | skin morphogenesis (GO:0043589) | 2.50914050 |
| 144 | epithelial cell-cell adhesion (GO:0090136) | 2.46980968 |
| 145 | negative regulation of cell size (GO:0045792) | 2.44367596 |
| 146 | regulation of cholesterol storage (GO:0010885) | 2.43660144 |
| 147 | cell-substrate adherens junction assembly (GO:0007045) | 2.43106628 |
| 148 | focal adhesion assembly (GO:0048041) | 2.43106628 |
| 149 | regulation of pseudopodium assembly (GO:0031272) | 2.41218122 |
| 150 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.40461546 |
| 151 | ceramide catabolic process (GO:0046514) | 2.39107840 |
| 152 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.38257458 |
| 153 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.37922334 |
| 154 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.37129525 |
| 155 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.37004346 |
| 156 | NADPH regeneration (GO:0006740) | 2.36961958 |
| 157 | sphingolipid catabolic process (GO:0030149) | 2.36360974 |
| 158 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.36052462 |
| 159 | modulation by symbiont of host cellular process (GO:0044068) | 2.35674059 |
| 160 | maternal placenta development (GO:0001893) | 2.34374199 |
| 161 | cell-substrate junction assembly (GO:0007044) | 2.33322629 |
| 162 | semaphorin-plexin signaling pathway (GO:0071526) | 2.32785378 |
| 163 | tricarboxylic acid metabolic process (GO:0072350) | 2.31583305 |
| 164 | negative regulation of viral release from host cell (GO:1902187) | 2.30684695 |
| 165 | detection of bacterium (GO:0016045) | 2.30677647 |
| 166 | membrane lipid catabolic process (GO:0046466) | 2.30372059 |
| 167 | fibril organization (GO:0097435) | 2.28704574 |
| 168 | endocytic recycling (GO:0032456) | 2.28303087 |
| 169 | regulation of extracellular matrix organization (GO:1903053) | 2.26718791 |
| 170 | actin filament depolymerization (GO:0030042) | 2.26136654 |
| 171 | amyloid precursor protein catabolic process (GO:0042987) | 2.25075441 |
| 172 | regulation of cellular extravasation (GO:0002691) | 2.24447097 |
| 173 | oxaloacetate metabolic process (GO:0006107) | 2.23970075 |
| 174 | positive regulation of extracellular matrix organization (GO:1903055) | 2.23567204 |
| 175 | response to thyroid hormone (GO:0097066) | 2.23560284 |
| 176 | negative regulation of fatty acid transport (GO:2000192) | 2.23559072 |
| 177 | positive regulation of nuclease activity (GO:0032075) | 2.23449938 |
| 178 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.23359828 |
| 179 | NIK/NF-kappaB signaling (GO:0038061) | 2.22927170 |
| 180 | detection of other organism (GO:0098543) | 2.22858336 |
| 181 | positive regulation by symbiont of host defense response (GO:0052509) | 2.22636742 |
| 182 | modulation by symbiont of host defense response (GO:0052031) | 2.22636742 |
| 183 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.22636742 |
| 184 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.22636742 |
| 185 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.22636742 |
| 186 | modulation by symbiont of host immune response (GO:0052553) | 2.22636742 |
| 187 | hyaluronan catabolic process (GO:0030214) | 2.21309528 |
| 188 | apoptotic cell clearance (GO:0043277) | 2.20967911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.36235024 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.99699634 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.36780945 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.88098847 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.36200106 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.86189674 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.72129669 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.34167314 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.86021525 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.63063673 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.28414841 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 1.92468820 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90443833 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.90077761 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87772746 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85799313 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84621193 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.80830513 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80354119 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73314252 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.72223469 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.68613527 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58582007 |
| 24 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.52571745 |
| 25 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.50884059 |
| 26 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.49920848 |
| 27 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.49869691 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43779086 |
| 29 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.39397359 |
| 30 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.38765545 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37995226 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37912654 |
| 33 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37264858 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35460077 |
| 35 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.34659162 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.32211793 |
| 37 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.32058278 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29243811 |
| 39 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.29005941 |
| 40 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28456287 |
| 41 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27841656 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27811801 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25737296 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23839064 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.23373398 |
| 46 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.23303850 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23251371 |
| 48 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.22054740 |
| 49 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.21971123 |
| 50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21716380 |
| 51 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.21622229 |
| 52 | ATF3_27146783_Chip-Seq_COLON_Human | 1.21102660 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21070549 |
| 54 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20852268 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20729028 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20049135 |
| 57 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.19848336 |
| 58 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19791672 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18359970 |
| 60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16792736 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15863211 |
| 62 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15372932 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15368885 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14071751 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13357729 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13337351 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11999016 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11830874 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11600061 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11310020 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10378567 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10074075 |
| 73 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08539640 |
| 74 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.08161124 |
| 75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07682822 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.07568080 |
| 77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07541007 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07263271 |
| 79 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.06460319 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.04799202 |
| 81 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.04130409 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02567288 |
| 83 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02505691 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02456225 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01740769 |
| 86 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01382094 |
| 87 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01349256 |
| 88 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98566079 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97318977 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96871654 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96695420 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96327271 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96111884 |
| 94 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94464838 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94170160 |
| 96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91965105 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90987115 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89335891 |
| 99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85906504 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.85689171 |
| 101 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.84490341 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84104512 |
| 103 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82349717 |
| 104 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.81765510 |
| 105 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80543018 |
| 106 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80017995 |
| 107 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79363426 |
| 108 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78682664 |
| 109 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.78271314 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78125620 |
| 111 | P68_20966046_ChIP-Seq_HELA_Human | 0.78027097 |
| 112 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.76994261 |
| 113 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.76902932 |
| 114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.76650346 |
| 115 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.76650346 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.76193343 |
| 117 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75955938 |
| 118 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74659534 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.74237220 |
| 120 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.73434595 |
| 121 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.73090975 |
| 122 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.72838634 |
| 123 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.71839439 |
| 124 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70858384 |
| 125 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.70808767 |
| 126 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.70759705 |
| 127 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70516759 |
| 128 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.70369060 |
| 129 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.70354121 |
| 130 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.70263430 |
| 131 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.70066836 |
| 132 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.69906210 |
| 133 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.68381508 |
| 134 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67579749 |
| 135 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.66481630 |
| 136 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.66031389 |
| 137 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.66010658 |
| 138 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.65740239 |
| 139 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.64913054 |
| 140 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.64671358 |
| 141 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.64326106 |
| 142 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63781595 |
| 143 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.63666232 |
| 144 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.62462716 |
| 145 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.62291099 |
| 146 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.62171388 |
| 147 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.62056097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.09870625 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.89956805 |
| 3 | MP0005365_abnormal_bile_salt | 5.32115395 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.21613607 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.23832490 |
| 6 | MP0009840_abnormal_foam_cell | 3.71293283 |
| 7 | MP0003252_abnormal_bile_duct | 3.50479279 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.47076827 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.00827865 |
| 10 | MP0005083_abnormal_biliary_tract | 2.62178069 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.56551157 |
| 12 | MP0008260_abnormal_autophagy | 2.52564264 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.50666260 |
| 14 | MP0005332_abnormal_amino_acid | 2.47407550 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.34780569 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.13183343 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 2.05859216 |
| 18 | MP0000609_abnormal_liver_physiology | 2.04375176 |
| 19 | MP0003566_abnormal_cell_adhesion | 2.04180580 |
| 20 | MP0005409_darkened_coat_color | 1.84386876 |
| 21 | MP0003195_calcinosis | 1.84095045 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.81792416 |
| 23 | MP0001849_ear_inflammation | 1.77563264 |
| 24 | MP0003868_abnormal_feces_composition | 1.75249600 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.75128587 |
| 26 | MP0000604_amyloidosis | 1.73386423 |
| 27 | MP0002796_impaired_skin_barrier | 1.64802152 |
| 28 | MP0003329_amyloid_beta_deposits | 1.61007294 |
| 29 | MP0004130_abnormal_muscle_cell | 1.58696298 |
| 30 | MP0003091_abnormal_cell_migration | 1.58030168 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.56905519 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.56723761 |
| 33 | MP0009278_abnormal_bone_marrow | 1.56063671 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.55287278 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 1.54970766 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54562818 |
| 37 | MP0000678_abnormal_parathyroid_gland | 1.47347793 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.47020515 |
| 39 | MP0004272_abnormal_basement_membrane | 1.44773693 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.41917816 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.37790859 |
| 42 | MP0000858_altered_metastatic_potential | 1.36168208 |
| 43 | MP0005257_abnormal_intraocular_pressure | 1.35740470 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.35124238 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.34770195 |
| 46 | MP0005451_abnormal_body_composition | 1.34195001 |
| 47 | MP0005076_abnormal_cell_differentiation | 1.33085592 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.30266939 |
| 49 | MP0010234_abnormal_vibrissa_follicle | 1.28262155 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.25779669 |
| 51 | MP0005670_abnormal_white_adipose | 1.22465377 |
| 52 | MP0003279_aneurysm | 1.21957394 |
| 53 | MP0005023_abnormal_wound_healing | 1.19337395 |
| 54 | MP0002822_catalepsy | 1.19060352 |
| 55 | MP0004233_abnormal_muscle_weight | 1.18137063 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.17641589 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.16922242 |
| 58 | MP0005501_abnormal_skin_physiology | 1.15795579 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.10831191 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.09980256 |
| 61 | MP0001958_emphysema | 1.09927497 |
| 62 | MP0002078_abnormal_glucose_homeostasis | 1.07824055 |
| 63 | MP0005275_abnormal_skin_tensile | 1.06830360 |
| 64 | MP0000343_altered_response_to | 1.06149000 |
| 65 | MP0005535_abnormal_body_temperature | 1.05659718 |
| 66 | MP0002419_abnormal_innate_immunity | 1.03183912 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.02097791 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.02097791 |
| 69 | MP0004782_abnormal_surfactant_physiolog | 1.02014997 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 1.00806139 |
| 71 | MP0000003_abnormal_adipose_tissue | 0.99909589 |
| 72 | MP0005025_abnormal_response_to | 0.99121520 |
| 73 | MP0006138_congestive_heart_failure | 0.98370345 |
| 74 | MP0000490_abnormal_crypts_of | 0.97370045 |
| 75 | MP0000598_abnormal_liver_morphology | 0.97342296 |
| 76 | MP0002971_abnormal_brown_adipose | 0.95447953 |
| 77 | MP0005448_abnormal_energy_balance | 0.95229836 |
| 78 | MP0003690_abnormal_glial_cell | 0.94704559 |
| 79 | MP0001764_abnormal_homeostasis | 0.93742219 |
| 80 | MP0005334_abnormal_fat_pad | 0.93434901 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 0.92455289 |
| 82 | MP0002909_abnormal_adrenal_gland | 0.92339616 |
| 83 | MP0001756_abnormal_urination | 0.89300202 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.88332250 |
| 85 | MP0009764_decreased_sensitivity_to | 0.87245071 |
| 86 | MP0003172_abnormal_lysosome_physiology | 0.87140843 |
| 87 | MP0002896_abnormal_bone_mineralization | 0.85302078 |
| 88 | MP0002060_abnormal_skin_morphology | 0.85293310 |
| 89 | MP0003075_altered_response_to | 0.85096294 |
| 90 | MP0006082_CNS_inflammation | 0.84911578 |
| 91 | MP0002254_reproductive_system_inflammat | 0.84114369 |
| 92 | MP0003828_pulmonary_edema | 0.82536675 |
| 93 | MP0001915_intracranial_hemorrhage | 0.82477609 |
| 94 | MP0000249_abnormal_blood_vessel | 0.82220853 |
| 95 | MP0000767_abnormal_smooth_muscle | 0.82182537 |
| 96 | MP0009780_abnormal_chondrocyte_physiolo | 0.81787209 |
| 97 | MP0005330_cardiomyopathy | 0.81246530 |
| 98 | MP0009931_abnormal_skin_appearance | 0.81208618 |
| 99 | MP0009785_altered_susceptibility_to | 0.79481567 |
| 100 | MP0008874_decreased_physiological_sensi | 0.78602498 |
| 101 | MP0004859_abnormal_synaptic_plasticity | 0.78581425 |
| 102 | MP0001216_abnormal_epidermal_layer | 0.77742011 |
| 103 | MP0003724_increased_susceptibility_to | 0.75438242 |
| 104 | MP0001790_abnormal_immune_system | 0.74850810 |
| 105 | MP0005387_immune_system_phenotype | 0.74850810 |
| 106 | MP0009763_increased_sensitivity_to | 0.73888462 |
| 107 | MP0008469_abnormal_protein_level | 0.72488542 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.71098434 |
| 109 | MP0005375_adipose_tissue_phenotype | 0.70998312 |
| 110 | MP0003448_altered_tumor_morphology | 0.69561634 |
| 111 | MP0005000_abnormal_immune_tolerance | 0.68937861 |
| 112 | MP0005166_decreased_susceptibility_to | 0.68807199 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.68731544 |
| 114 | MP0000685_abnormal_immune_system | 0.68680773 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.68012575 |
| 116 | MP0005621_abnormal_cell_physiology | 0.67836920 |
| 117 | MP0000462_abnormal_digestive_system | 0.67112410 |
| 118 | MP0008872_abnormal_physiological_respon | 0.66421163 |
| 119 | MP0000747_muscle_weakness | 0.66005672 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.65327429 |
| 121 | MP0003953_abnormal_hormone_level | 0.64178574 |
| 122 | MP0004510_myositis | 0.63564482 |
| 123 | MP0005167_abnormal_blood-brain_barrier | 0.63446422 |
| 124 | MP0004264_abnormal_extraembryonic_tissu | 0.63398771 |
| 125 | MP0004858_abnormal_nervous_system | 0.58458973 |
| 126 | MP0003303_peritoneal_inflammation | 0.58354890 |
| 127 | MP0003633_abnormal_nervous_system | 0.58060914 |
| 128 | MP0003436_decreased_susceptibility_to | 0.57150662 |
| 129 | MP0004043_abnormal_pH_regulation | 0.56873284 |
| 130 | MP0006036_abnormal_mitochondrial_physio | 0.56625713 |
| 131 | MP0005220_abnormal_exocrine_pancreas | 0.56596961 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.54489334 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.54412839 |
| 134 | MP0002876_abnormal_thyroid_physiology | 0.54295202 |
| 135 | MP0009765_abnormal_xenobiotic_induced | 0.54230758 |
| 136 | MP0005266_abnormal_metabolism | 0.52525437 |
| 137 | MP0005647_abnormal_sex_gland | 0.52068501 |
| 138 | MP0005376_homeostasis/metabolism_phenot | 0.51220072 |
| 139 | MP0003183_abnormal_peptide_metabolism | 0.49927743 |
| 140 | MP0004147_increased_porphyrin_level | 0.49835038 |
| 141 | MP0010368_abnormal_lymphatic_system | 0.49770170 |
| 142 | MP0002269_muscular_atrophy | 0.49542891 |
| 143 | MP0002090_abnormal_vision | 0.47915960 |
| 144 | MP0002069_abnormal_eating/drinking_beha | 0.47787500 |
| 145 | MP0000639_abnormal_adrenal_gland | 0.47568368 |
| 146 | MP0002970_abnormal_white_adipose | 0.47300123 |
| 147 | MP0009115_abnormal_fat_cell | 0.46115301 |
| 148 | MP0000538_abnormal_urinary_bladder | 0.45918593 |
| 149 | MP0004947_skin_inflammation | 0.45305242 |
| 150 | MP0001661_extended_life_span | 0.44872892 |
| 151 | MP0003011_delayed_dark_adaptation | 0.42391642 |
| 152 | MP0000751_myopathy | 0.40923804 |
| 153 | MP0001663_abnormal_digestive_system | 0.40140425 |
| 154 | MP0004270_analgesia | 0.39736186 |
| 155 | MP0003631_nervous_system_phenotype | 0.39612172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.82493650 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.47170717 |
| 3 | Xanthomatosis (HP:0000991) | 5.31064849 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 5.27254330 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.87072138 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.67814398 |
| 7 | Complement deficiency (HP:0004431) | 4.41335663 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.30759135 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.07574147 |
| 10 | Ketosis (HP:0001946) | 4.02558092 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.91117161 |
| 12 | Hyperammonemia (HP:0001987) | 3.88127811 |
| 13 | Hypolipoproteinemia (HP:0010981) | 3.70738847 |
| 14 | Hyperglycinuria (HP:0003108) | 3.69916850 |
| 15 | Hyperglycinemia (HP:0002154) | 3.56280088 |
| 16 | Epidermoid cyst (HP:0200040) | 3.54669319 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.51745492 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 3.51745492 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.47133327 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.41713521 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.41711590 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.41067301 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.35982425 |
| 24 | Ketoacidosis (HP:0001993) | 3.30764988 |
| 25 | Fat malabsorption (HP:0002630) | 3.22362486 |
| 26 | Abnormality of complement system (HP:0005339) | 3.17268883 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.17069666 |
| 28 | Joint hemorrhage (HP:0005261) | 3.15155658 |
| 29 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.14428323 |
| 30 | Protrusio acetabuli (HP:0003179) | 3.04712718 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.02677235 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.02145357 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.93628542 |
| 34 | Premature rupture of membranes (HP:0001788) | 2.91234083 |
| 35 | Vertebral compression fractures (HP:0002953) | 2.90809310 |
| 36 | Increased connective tissue (HP:0009025) | 2.83125626 |
| 37 | Hyperbilirubinemia (HP:0002904) | 2.82225476 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 2.80021152 |
| 39 | Myocardial infarction (HP:0001658) | 2.74322223 |
| 40 | Gout (HP:0001997) | 2.71038181 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 2.70698513 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 2.68901901 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.68704810 |
| 44 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.68704810 |
| 45 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.68704810 |
| 46 | Eczematoid dermatitis (HP:0000976) | 2.68269940 |
| 47 | Skin nodule (HP:0200036) | 2.62347877 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 2.60988143 |
| 49 | Dysostosis multiplex (HP:0000943) | 2.60492503 |
| 50 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.57031066 |
| 51 | Upper limb amyotrophy (HP:0009129) | 2.55760824 |
| 52 | Distal upper limb amyotrophy (HP:0007149) | 2.55760824 |
| 53 | Loss of speech (HP:0002371) | 2.52965817 |
| 54 | Acanthocytosis (HP:0001927) | 2.52364094 |
| 55 | Thin bony cortex (HP:0002753) | 2.52314373 |
| 56 | Distal lower limb amyotrophy (HP:0008944) | 2.52266401 |
| 57 | Cholelithiasis (HP:0001081) | 2.47965989 |
| 58 | Abnormality of nucleobase metabolism (HP:0010932) | 2.46379338 |
| 59 | Late onset (HP:0003584) | 2.45812589 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.43011168 |
| 61 | Sensorimotor neuropathy (HP:0007141) | 2.42601409 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.40954531 |
| 63 | Cerebral aneurysm (HP:0004944) | 2.37171514 |
| 64 | Mitral stenosis (HP:0001718) | 2.33757718 |
| 65 | Delayed CNS myelination (HP:0002188) | 2.32532889 |
| 66 | Increased variability in muscle fiber diameter (HP:0003557) | 2.32247516 |
| 67 | Neonatal onset (HP:0003623) | 2.31053484 |
| 68 | Metabolic acidosis (HP:0001942) | 2.30652574 |
| 69 | Glomerulonephritis (HP:0000099) | 2.25013257 |
| 70 | Distal lower limb muscle weakness (HP:0009053) | 2.24966330 |
| 71 | Mucopolysacchariduria (HP:0008155) | 2.24154249 |
| 72 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24154249 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 2.23052857 |
| 74 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.21933470 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.21445766 |
| 76 | Hydroxyprolinuria (HP:0003080) | 2.21445766 |
| 77 | Global brain atrophy (HP:0002283) | 2.20679810 |
| 78 | Malnutrition (HP:0004395) | 2.19125692 |
| 79 | Neurofibrillary tangles (HP:0002185) | 2.17591803 |
| 80 | Cervical subluxation (HP:0003308) | 2.17050685 |
| 81 | Amyloidosis (HP:0011034) | 2.15445396 |
| 82 | Myopathic facies (HP:0002058) | 2.15080202 |
| 83 | Achilles tendon contracture (HP:0001771) | 2.14856950 |
| 84 | Steatorrhea (HP:0002570) | 2.13558149 |
| 85 | Abnormality of serum amino acid levels (HP:0003112) | 2.12961495 |
| 86 | Exercise-induced myalgia (HP:0003738) | 2.12833389 |
| 87 | Cerebral inclusion bodies (HP:0100314) | 2.10472440 |
| 88 | Abnormality of macrophages (HP:0004311) | 2.10165470 |
| 89 | Poikilocytosis (HP:0004447) | 2.08995677 |
| 90 | Hemorrhage of the eye (HP:0011885) | 2.08908282 |
| 91 | Hyperparathyroidism (HP:0000843) | 2.08672336 |
| 92 | Spinal rigidity (HP:0003306) | 2.08102398 |
| 93 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.07795314 |
| 94 | Gingivitis (HP:0000230) | 2.07481872 |
| 95 | Spastic diplegia (HP:0001264) | 2.06959066 |
| 96 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05609540 |
| 97 | Irritability (HP:0000737) | 2.05305612 |
| 98 | Ileus (HP:0002595) | 2.04637710 |
| 99 | Status epilepticus (HP:0002133) | 2.04232582 |
| 100 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04163905 |
| 101 | Flat acetabular roof (HP:0003180) | 2.03875239 |
| 102 | Esophageal varix (HP:0002040) | 2.03581736 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 2.03257437 |
| 104 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03257437 |
| 105 | Abnormal gallbladder physiology (HP:0012438) | 1.99322939 |
| 106 | Cholecystitis (HP:0001082) | 1.99322939 |
| 107 | Nuclear cataract (HP:0100018) | 1.99158019 |
| 108 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.97740988 |
| 109 | Hand muscle atrophy (HP:0009130) | 1.95715119 |
| 110 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93755620 |
| 111 | Hyperacusis (HP:0010780) | 1.93385664 |
| 112 | Asymmetric septal hypertrophy (HP:0001670) | 1.93368964 |
| 113 | Increased IgE level (HP:0003212) | 1.92506878 |
| 114 | Atrophic scars (HP:0001075) | 1.92489201 |
| 115 | Spontaneous abortion (HP:0005268) | 1.91813998 |
| 116 | Increased cerebral lipofuscin (HP:0011813) | 1.89899829 |
| 117 | Reticulocytosis (HP:0001923) | 1.89189111 |
| 118 | Aneurysm (HP:0002617) | 1.89158899 |
| 119 | Hypertriglyceridemia (HP:0002155) | 1.87821211 |
| 120 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.87648074 |
| 121 | Osteolytic defects of the hand bones (HP:0009699) | 1.87648074 |
| 122 | Abnormality of the Achilles tendon (HP:0005109) | 1.87296466 |
| 123 | Abnormality of the gallbladder (HP:0005264) | 1.85351007 |
| 124 | Pancreatitis (HP:0001733) | 1.85019763 |
| 125 | Polycythemia (HP:0001901) | 1.84475618 |
| 126 | Increased purine levels (HP:0004368) | 1.84325670 |
| 127 | Hyperuricemia (HP:0002149) | 1.84325670 |
| 128 | Obstructive sleep apnea (HP:0002870) | 1.82868944 |
| 129 | Cellulitis (HP:0100658) | 1.81590309 |
| 130 | Fragile skin (HP:0001030) | 1.81124976 |
| 131 | Symptomatic seizures (HP:0011145) | 1.81013807 |
| 132 | Vascular calcification (HP:0004934) | 1.80601256 |
| 133 | Brushfield spots (HP:0001088) | 1.80270241 |
| 134 | Myoglobinuria (HP:0002913) | 1.80038598 |
| 135 | Hyperglycemia (HP:0003074) | 1.79291056 |
| 136 | Gingival bleeding (HP:0000225) | 1.79055386 |
| 137 | Axonal loss (HP:0003447) | 1.77714670 |
| 138 | Bone pain (HP:0002653) | 1.77629431 |
| 139 | Gastrointestinal dysmotility (HP:0002579) | 1.76815326 |
| 140 | Broad face (HP:0000283) | 1.76632515 |
| 141 | Alkalosis (HP:0001948) | 1.76418012 |
| 142 | J-shaped sella turcica (HP:0002680) | 1.76408498 |
| 143 | Blue sclerae (HP:0000592) | 1.75487415 |
| 144 | Dilatation of the ascending aorta (HP:0005111) | 1.74828795 |
| 145 | Back pain (HP:0003418) | 1.74247872 |
| 146 | Lethargy (HP:0001254) | 1.72291142 |
| 147 | Death in childhood (HP:0003819) | 1.71999014 |
| 148 | Disproportionate tall stature (HP:0001519) | 1.71712768 |
| 149 | Colitis (HP:0002583) | 1.70870788 |
| 150 | Lower limb amyotrophy (HP:0007210) | 1.69208682 |
| 151 | Nephritis (HP:0000123) | 1.69157578 |
| 152 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68631287 |
| 153 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68631287 |
| 154 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68631287 |
| 155 | Abdominal distention (HP:0003270) | 1.68353839 |
| 156 | Stroke (HP:0001297) | 1.68040287 |
| 157 | Wormian bones (HP:0002645) | 1.67471648 |
| 158 | Hypertensive crisis (HP:0100735) | 1.66783381 |
| 159 | Supranuclear gaze palsy (HP:0000605) | 1.66262249 |
| 160 | Atelectasis (HP:0100750) | 1.65606425 |
| 161 | Hypophosphatemia (HP:0002148) | 1.64734143 |
| 162 | Pathologic fracture (HP:0002756) | 1.63661192 |
| 163 | Vascular tortuosity (HP:0004948) | 1.62551952 |
| 164 | Neuronal loss in central nervous system (HP:0002529) | 1.61730406 |
| 165 | Emphysema (HP:0002097) | 1.60735178 |
| 166 | Type 1 muscle fiber predominance (HP:0003803) | 1.60247114 |
| 167 | Nonimmune hydrops fetalis (HP:0001790) | 1.59369810 |
| 168 | Slender build (HP:0001533) | 1.59200316 |
| 169 | Elevated alkaline phosphatase (HP:0003155) | 1.58876617 |
| 170 | Vacuolated lymphocytes (HP:0001922) | 1.58309632 |
| 171 | Arterial tortuosity (HP:0005116) | 1.57942082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.20014011 |
| 2 | ERN1 | 4.13739272 |
| 3 | PRPF4B | 3.59878945 |
| 4 | BCKDK | 3.36062054 |
| 5 | FGFR4 | 3.09993966 |
| 6 | MAP3K9 | 2.77962543 |
| 7 | PKN2 | 2.73745149 |
| 8 | SIK1 | 2.66633611 |
| 9 | SMG1 | 2.38175519 |
| 10 | RIPK1 | 2.09369086 |
| 11 | IRAK3 | 2.03057689 |
| 12 | KSR2 | 1.95456653 |
| 13 | TAOK3 | 1.73220290 |
| 14 | TESK1 | 1.72421818 |
| 15 | CDK12 | 1.71535106 |
| 16 | LMTK2 | 1.66772283 |
| 17 | TAOK2 | 1.62708331 |
| 18 | CAMKK1 | 1.62166813 |
| 19 | PTK6 | 1.61114976 |
| 20 | INSRR | 1.60418738 |
| 21 | MAP2K4 | 1.59287353 |
| 22 | MAP3K10 | 1.56800487 |
| 23 | EPHA2 | 1.53969688 |
| 24 | MAP3K3 | 1.50768709 |
| 25 | RET | 1.49222910 |
| 26 | GRK6 | 1.46567872 |
| 27 | NME2 | 1.45713463 |
| 28 | MAP3K7 | 1.45564553 |
| 29 | MAP3K11 | 1.41325338 |
| 30 | CAMK1D | 1.32907546 |
| 31 | DDR2 | 1.32627205 |
| 32 | MAP3K13 | 1.32116921 |
| 33 | DAPK2 | 1.30850083 |
| 34 | PRKG2 | 1.29913355 |
| 35 | EPHA4 | 1.29247691 |
| 36 | CDC42BPA | 1.28540616 |
| 37 | FRK | 1.27284388 |
| 38 | PAK4 | 1.21519840 |
| 39 | TESK2 | 1.21148899 |
| 40 | PDGFRA | 1.20288512 |
| 41 | NTRK1 | 1.20067943 |
| 42 | TAOK1 | 1.18096637 |
| 43 | PAK6 | 1.16961522 |
| 44 | FGFR2 | 1.16160927 |
| 45 | SIK3 | 1.14698961 |
| 46 | CAMK1G | 1.11824094 |
| 47 | SIK2 | 1.11168596 |
| 48 | EPHB1 | 1.08952071 |
| 49 | JAK2 | 1.07465226 |
| 50 | TTN | 1.05953135 |
| 51 | MAP3K2 | 1.05140174 |
| 52 | PRKD2 | 1.04459421 |
| 53 | JAK1 | 1.03778010 |
| 54 | SGK3 | 1.03196720 |
| 55 | MAP3K6 | 0.96415820 |
| 56 | STK38 | 0.95812549 |
| 57 | EEF2K | 0.95341158 |
| 58 | MST1R | 0.94261878 |
| 59 | MAPK11 | 0.92521815 |
| 60 | PDPK1 | 0.92407210 |
| 61 | MAP3K4 | 0.91976422 |
| 62 | PDK2 | 0.91437970 |
| 63 | PTK2 | 0.90898057 |
| 64 | TYK2 | 0.90573426 |
| 65 | BMX | 0.89154256 |
| 66 | PRKCH | 0.88663417 |
| 67 | ICK | 0.86393364 |
| 68 | MAP4K1 | 0.84764639 |
| 69 | EPHA3 | 0.84675391 |
| 70 | RPS6KA2 | 0.84254003 |
| 71 | ARAF | 0.84078971 |
| 72 | PHKG1 | 0.83422773 |
| 73 | PHKG2 | 0.83422773 |
| 74 | KSR1 | 0.83012039 |
| 75 | ZAP70 | 0.81207543 |
| 76 | FGFR3 | 0.80755887 |
| 77 | PDK1 | 0.79674061 |
| 78 | TYRO3 | 0.78396054 |
| 79 | PRKAA2 | 0.77842395 |
| 80 | MAP2K1 | 0.77205950 |
| 81 | MOS | 0.77082139 |
| 82 | EPHB2 | 0.77032560 |
| 83 | MET | 0.75357893 |
| 84 | PRKCZ | 0.73936857 |
| 85 | LATS1 | 0.73822430 |
| 86 | ERBB4 | 0.73342452 |
| 87 | MAP3K1 | 0.70824640 |
| 88 | TGFBR2 | 0.70265239 |
| 89 | TBK1 | 0.70116770 |
| 90 | MAP3K14 | 0.69527891 |
| 91 | MAP3K8 | 0.68780130 |
| 92 | PRKAA1 | 0.68479625 |
| 93 | NEK1 | 0.66299531 |
| 94 | PRKD3 | 0.64503592 |
| 95 | PAK3 | 0.64275398 |
| 96 | MINK1 | 0.64053730 |
| 97 | NTRK2 | 0.63414123 |
| 98 | BLK | 0.62582092 |
| 99 | MATK | 0.62544344 |
| 100 | PINK1 | 0.62300537 |
| 101 | MAPK12 | 0.61577640 |
| 102 | MAPKAPK3 | 0.58819229 |
| 103 | STK11 | 0.57752405 |
| 104 | PRKD1 | 0.56875567 |
| 105 | TRPM7 | 0.55942683 |
| 106 | PRKACG | 0.54121380 |
| 107 | ERBB2 | 0.53886910 |
| 108 | PDGFRB | 0.52580091 |
| 109 | NTRK3 | 0.52271138 |
| 110 | MAPK7 | 0.50020816 |
| 111 | FLT3 | 0.49552571 |
| 112 | MARK2 | 0.48981045 |
| 113 | FES | 0.48355518 |
| 114 | DYRK1B | 0.47598079 |
| 115 | MAPKAPK2 | 0.46696684 |
| 116 | RPS6KC1 | 0.46403488 |
| 117 | RPS6KL1 | 0.46403488 |
| 118 | LATS2 | 0.45091197 |
| 119 | HIPK2 | 0.44887389 |
| 120 | CSK | 0.44352633 |
| 121 | SGK494 | 0.43411175 |
| 122 | SGK223 | 0.43411175 |
| 123 | MAPK4 | 0.43230615 |
| 124 | CSF1R | 0.43011662 |
| 125 | ABL2 | 0.42812500 |
| 126 | ITK | 0.42508145 |
| 127 | CDK5 | 0.42309095 |
| 128 | JAK3 | 0.42207044 |
| 129 | MARK1 | 0.41928112 |
| 130 | MAP2K2 | 0.41596833 |
| 131 | DMPK | 0.40653214 |
| 132 | LRRK2 | 0.39828036 |
| 133 | SGK2 | 0.39540204 |
| 134 | RIPK4 | 0.38980697 |
| 135 | IRAK4 | 0.38919453 |
| 136 | PIK3CG | 0.38822191 |
| 137 | MTOR | 0.38435732 |
| 138 | PAK2 | 0.38018141 |
| 139 | FER | 0.38007218 |
| 140 | MAP2K3 | 0.37877596 |
| 141 | CDK9 | 0.36916311 |
| 142 | IRAK2 | 0.35501763 |
| 143 | CAMK4 | 0.35463574 |
| 144 | FGR | 0.35289271 |
| 145 | SCYL2 | 0.34786061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.87882621 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.64191413 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.24722948 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.16570900 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.95647261 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89754411 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48173578 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.47762353 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34717783 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.25292274 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.18866837 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.10894263 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10538190 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96264440 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 1.90617470 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86281656 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81551423 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.80433881 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.79631677 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.79041626 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74992788 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.64756934 |
| 23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.64587081 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.62625979 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.54918291 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54475492 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52173256 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.52089754 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50130837 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46199125 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43156072 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.36163090 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30831579 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30610767 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.30500622 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29810361 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28647184 |
| 38 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.27121056 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.20736675 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.19527056 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16414426 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14905653 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.13417952 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.12297616 |
| 45 | Bladder cancer_Homo sapiens_hsa05219 | 1.11544285 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10161044 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.09666853 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09547921 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.08120692 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 1.06177133 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03463216 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03140620 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02482641 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02361097 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02235090 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02156818 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01796920 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 1.01605173 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01170764 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00893941 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96155887 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94288989 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92137450 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.92073312 |
| 65 | Leishmaniasis_Homo sapiens_hsa05140 | 0.91338954 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91132190 |
| 67 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88261490 |
| 68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.86872674 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86095782 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85393132 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85172815 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84541061 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.83416214 |
| 74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82752192 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.82719555 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.81573488 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79630453 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78105928 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77908622 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.77822107 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77815717 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.77181933 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76216257 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.75027420 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74921394 |
| 86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74882254 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72865249 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71869034 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71822677 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.71816692 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71132851 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.68450164 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.67670481 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67616368 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.66012030 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65186904 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.63931498 |
| 98 | Malaria_Homo sapiens_hsa05144 | 0.63791499 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63617744 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63347085 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62215343 |
| 102 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61649245 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.60893840 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59880524 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.58818327 |
| 106 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58630942 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58549120 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58377489 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57530702 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57090985 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57008757 |
| 112 | Adherens junction_Homo sapiens_hsa04520 | 0.56412792 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56181971 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54997349 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53776375 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53634818 |
| 117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52196801 |
| 118 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51661303 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50570369 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48675918 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47418145 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46657570 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.45363305 |
| 124 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44485862 |
| 125 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44339673 |
| 126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42533178 |
| 127 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41977383 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40374264 |
| 129 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40193195 |
| 130 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39465183 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38026648 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37260795 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36239111 |
| 134 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36163447 |
| 135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33705438 |
| 136 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22369961 |
| 137 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.21614225 |
| 138 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.20537647 |
| 139 | Insulin secretion_Homo sapiens_hsa04911 | 0.18617528 |
| 140 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18615157 |
| 141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18354422 |
| 142 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.17548898 |
| 143 | Mineral absorption_Homo sapiens_hsa04978 | 0.17103162 |
| 144 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.16507463 |
| 145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.15936225 |
| 146 | Lysosome_Homo sapiens_hsa04142 | 0.15795749 |
| 147 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15532713 |
| 148 | Metabolic pathways_Homo sapiens_hsa01100 | 0.14472290 |
| 149 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.14075361 |
| 150 | Salivary secretion_Homo sapiens_hsa04970 | 0.13680018 |
| 151 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.10672408 |
| 152 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.09803461 |
| 153 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.09532304 |
| 154 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.08604700 |
| 155 | Renin secretion_Homo sapiens_hsa04924 | 0.08553848 |
| 156 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.07324041 |

